ImmunoGen Inc
DUS:IMU
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
I
|
ImmunoGen Inc
DUS:IMU
|
US |
|
F
|
Franklin Resources Inc
DUS:FRK
|
US |
|
N
|
National Bank of Canada
XMUN:NBC
|
CA |
|
Intesa Sanpaolo SpA
F:IESJ
|
IT |
|
A
|
Afine Investments Ltd
JSE:ANI
|
ZA |
|
Legrand SA
PAR:LR
|
FR |
|
Schibsted ASA
LSE:0MHM
|
NO |
|
Substrate Artificial Inteligence SA
OTC:SUIAF
|
ES |
|
A
|
AXA SA
BMV:AXAN
|
FR |
|
M
|
Mobico Group PLC
XMUN:3NA
|
UK |
|
C
|
Commerzbank AG
F:CBK
|
DE |
|
S
|
Swire Pacific Ltd
OTC:SWRAY
|
HK |
|
I
|
Innocan Pharma Corp
XMUN:IP4
|
IL |
|
B
|
Benchmark Electronics Inc
SWB:BMU
|
US |
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is IMU's stock price target?
Not Available
IMU does not have any price targets made by Wall Street professionals.
What is the Revenue forecast for ImmunoGen Inc?
Projected CAGR
75%
Over the last 9 years, the compound annual growth rate for Revenue has been 7%. The projected CAGR for the next 4 years is 75%.